Pancreatic ductal adenocarcinoma is one of the most aggressive and deadliest forms of cancer. Treatment options are limited because symptoms typically do not appear until the disease is advanced and complete surgical resection ...
Jun 2, 2016
0
3
Massachusetts General Hospital (MGH) investigators have identified the first potential molecular treatment target for the most common form of pancreatic cancer, which kills more than 90 percent of patients. Along with finding ...
May 12, 2016
0
13
Researchers from several major U.S. universities and ITMO University in Russia have identified a number of new driver mutations in lung cancer cells that may be responsive to genomically targeted therapies and to immunotherapy.
May 10, 2016
0
29
University of California, Irvine scientists who study how circadian rhythms—our own body clocks—control liver function have discovered that cancerous lung tumors can hijack this process and profoundly alter metabolism.
May 5, 2016
0
38
The most aggressive form of pancreatic cancer - often described as one of the hardest malignancies to diagnose and treat—thrives in the presence of neighboring tumor cells undergoing a particular form of "orchestrated cell ...
Apr 22, 2016
0
63
Researchers from the University of Liverpool working with colleagues from around the globe have found an explanation for how pancreatic cancer spreads to the liver. These findings potentially hold the key to stopping this ...
Apr 18, 2016
0
39
Cancer cells use a mutant gene to coerce neighbouring healthy tissue into helping with the disease's growth and spread, a major new study reports.
Apr 14, 2016
0
4
The results of an early-stage (phase 1b) clinical trial for pancreatic cancer show that an experimental therapy can control tumors well enough to make some patients eligible for surgery, according to data published in The ...
Apr 4, 2016
0
168
Researchers from the universities of Granada, Barcelona and Jaen prove that maslinic acid, a natural triterpene found in high concentrations in the waxy skin of olives is effective in Caco-2 p53-deficient colon adenocarcinoma ...
Mar 10, 2016
0
4
A joint study by University of Colorado Cancer Center and Memorial Sloan Kettering Cancer Center published in the Journal of Thoracic Oncology shows two distinct causes of HER2 activation in lung cancer: mutation of the gene ...
Jan 28, 2016
0
7
